Inactief instrument

Koers Serendex Pharmaceuticals A/S

Aandelen

Duur

Periode

Stijl

Serendex Pharmaceuticals A/S : Minutes of Serendex’s Extraordinary General Meeting 2016	12-07-16
Serendex Pharmaceuticals A/S : Savara Pharmaceuticals acquires Serendex	21-06-16
Serendex Pharmaceuticals A/S : First patient dosed in Serendex’s pivotal trial for PAP	25-05-16
Serendex Pharmaceuticals A/S : signs license agreement with Japanese partner	12-05-16
Serendex Pharmaceuticals A/S : Delisting of Serendex as of 4 May 2016	02-05-16

Sector

	Vaira. 1 jan.	Kapi.
REGENERON PHARMACEUTICALS, INC.	+9,15%	106 mld.
VERTEX PHARMACEUTICALS INCORPORATED	-1,08%	104 mld.
ARGENX SE	+6,49%	23,25 mld.
BIONTECH SE	-11,55%	22,5 mld.
GENMAB A/S	-7,15%	18,7 mld.
WUXI APPTEC CO., LTD.	-37,08%	17,95 mld.
BEIGENE, LTD.	-9,91%	16,99 mld.
NEUROCRINE BIOSCIENCES, INC.	+7,55%	14,26 mld.
SAREPTA THERAPEUTICS, INC.	+40,04%	12,76 mld.